249 related articles for article (PubMed ID: 6715121)
1. Effect of cyanidanol-3 on lysosomal enzyme activity of serum and granulocytes in chronic liver disease and active hepatitis.
Fehér J; Toncsev H; Sréter L; Cornides A; Kiss A
Int J Tissue React; 1984; 6(1):75-80. PubMed ID: 6715121
[TBL] [Abstract][Full Text] [Related]
2. Lysosomal enzymes in sera and granulocytes of patients with chronic liver diseases.
Fehér J; Toncsev H; Fehér E; Kiss A; Vasady A
Int J Tissue React; 1981 Mar; 3(1):31-7. PubMed ID: 7287055
[TBL] [Abstract][Full Text] [Related]
3. Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
Halmy L; Dávid K; Nagy I; Stotz G; Kelemen JT
Acta Physiol Hung; 1984; 64(3-4):461-70. PubMed ID: 6152370
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of chronic diseases of the liver with catergen].
Loginov AS; Dzhalalov KD; Blok IuE; Bendikov EA; Ausheva LKh
Ter Arkh; 1986; 58(2):73-6. PubMed ID: 3704945
[TBL] [Abstract][Full Text] [Related]
5. Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
Pár A; Paál M; Kádas I; Kerekes E; Jávor T
Acta Med Hung; 1983; 40(1):17-24. PubMed ID: 6664741
[TBL] [Abstract][Full Text] [Related]
6. Glycohydrolases and lysosomal stability in adjuvant induced arthritis.
Arumugham R; Bose SM
Ital J Biochem; 1980; 29(1):27-40. PubMed ID: 7380646
[TBL] [Abstract][Full Text] [Related]
7. Studies on the lysosomal enzyme system of the liver in rats undergoing swimming training.
Toncsev H; Frenkl R
Int J Sports Med; 1984 Jun; 5(3):152-5. PubMed ID: 6746178
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and experimental studies on changes in lysosomal enzyme activity in fatty livers (author's transl)].
Yamada J
Hokkaido Igaku Zasshi; 1978 May; 53(3):191-204. PubMed ID: 711125
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease.
Pár A; Horváth T; Beró T; Kádas I; Pakodi F; Jávor T
Acta Physiol Hung; 1984; 64(3-4):449-54. PubMed ID: 6152369
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of chronic hepatitis patients with catergen].
Karkishchenko NN; Okorokov AN; Fedorov NE; Laktionova AA; Sidorenko LF
Ter Arkh; 1986; 58(2):76-9. PubMed ID: 3704946
[TBL] [Abstract][Full Text] [Related]
11. Changes in lysosomal enzyme activities recognized in granulocytes from patients with carcinomas of the gastrointestinal tract.
Okada T; Taniguchi T; Kitsuta T; Kiyohashi A; Okabe H
Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2559-67. PubMed ID: 3209925
[No Abstract] [Full Text] [Related]
12. Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
Abonyi M; Kisfaludy S; Szalay F
Acta Physiol Hung; 1984; 64(3-4):455-60. PubMed ID: 6397971
[TBL] [Abstract][Full Text] [Related]
13. Influence of bioflavonoids on lysosomal acid hydrolases and lysosomal stability.
Rao CN; Rao VH; Steinmann B
Ital J Biochem; 1981; 30(1):46-53. PubMed ID: 7251340
[TBL] [Abstract][Full Text] [Related]
14. Acute carbon tetrachloride induced lysosomal membrane damage and the membrane protecting effect of a new dihydroquinoline-type antioxidant.
Toncsev H; Pollák Z; Kiss A; Sréter L; Fehér J
Int J Tissue React; 1982; 4(4):325-30. PubMed ID: 7169303
[TBL] [Abstract][Full Text] [Related]
15. Comparison of isoproterenol-induced changes in lysosomal enzyme activity in vivo and in vitro.
Macicková T; Navarová J; Urbancíkova M; Horáková K
Gen Physiol Biophys; 1999 Oct; 18 Spec No():86-91. PubMed ID: 10703725
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo demonstration of the cytoprotective effect of (+)-cyanidanol-3.
Altorjay I; Dalmi L; Sári B
Acta Physiol Hung; 1984; 64(3-4):471-4. PubMed ID: 6532130
[TBL] [Abstract][Full Text] [Related]
17. The effect of (+) --cyanidanol on lysosomal enzymes of I-cell fibroblasts.
Tavella D; Donnelly PV; Di Ferrante N
Tex Rep Biol Med; 1976; 34(2-4):307-14. PubMed ID: 20673
[TBL] [Abstract][Full Text] [Related]
18. Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases.
Pfliegler G; Boda Z; Dalmi L; Weisz G; Misz M; Beck P
Ther Hung; 1984; 32(1):19-25. PubMed ID: 6571189
[No Abstract] [Full Text] [Related]
19. Antishock effect of gabexate mesilate (FOY).
Oda T; Miyawaki T; Sameshima T; Miyao J; Arai Y; Yoshimine K; Yoshimura N
Prog Clin Biol Res; 1983; 111():293-307. PubMed ID: 6408649
[TBL] [Abstract][Full Text] [Related]
20. Effect of endotracheal anaesthesia on the activity of lysosomal enzymes in peripheral blood granulocytes.
Gaszynski W; Sulowska Z; Szpunar M; Siwik J; Kralkowski K
Anaesth Resusc Intensive Ther; 1976; 4(1):3-9. PubMed ID: 970615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
